> Detailanzeige

Meyer-Frießem, Christine H.; Malewicz, Nathalie M.; Rath, Sabrina; Ebel, Melanie; Kaisler, Miriam; Tegenthoff, Martin; Schildhauer, Thomas A.; Pogatzki-Zahn, Esther M.; Maier, Christoph; Zahn, Peter K.

Incidence, Time Course and Influence on Quality of Life of Intensive Care Unit-Acquired Weakness Symptoms in Long-Term Intensive Care Survivors

Literatur-
verwaltung

Zur
Merkliste

Lösche von
Merkliste

Per Whatsapp teilen

Schließen

Merkliste



Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
  • Medientyp: E-Artikel
  • Titel: Incidence, Time Course and Influence on Quality of Life of Intensive Care Unit-Acquired Weakness Symptoms in Long-Term Intensive Care Survivors
  • Beteiligte: Meyer-Frießem, Christine H.; Malewicz, Nathalie M.; Rath, Sabrina; Ebel, Melanie; Kaisler, Miriam; Tegenthoff, Martin; Schildhauer, Thomas A.; Pogatzki-Zahn, Esther M.; Maier, Christoph; Zahn, Peter K.
  • Erschienen: SAGE Publications, 2021
  • Erschienen in: Journal of Intensive Care Medicine
  • Sprache: Englisch
  • DOI: 10.1177/0885066620949178
  • ISSN: 0885-0666; 1525-1489
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:sec><jats:title>Purpose:</jats:title><jats:p> Intensive care unit-acquired weakness (ICUAW) can manifest as muscle weakness or neuropathy-like symptoms, with diagnosis remaining a challenge. Uncertainties surround the long-term cause and sequelae. Therefore, the purpose was to assess incidence, time course and long-term influence on quality of life (QoL) of symptoms in ICU survivors </jats:p></jats:sec><jats:sec><jats:title>Methods:</jats:title><jats:p> After ethical approval and registration ( www.drks.de : DRKS00011593), in a single-center cohort study all patients admitted to the ICU in 2007–2017 in a German university hospital were screened. Out of 1,860 patients (≥7d ICU care including ventilation support for ≥72 h, at least 6mo-10y after ICU) 636 were deceased, 912 survivors were contacted. </jats:p></jats:sec><jats:sec><jats:title>Results:</jats:title><jats:p> 149 former patients (age: 63.5 ± 13.1y; males: 73%; duration in ICU: 20.8 ± 15.7d; duration of ventilation: 16.5 ± 13.7 h; time post-ICU: 4.4 ± 2.7y, 5-10y: 43%) consented to be interviewed concerning occurrence, duration, recovery and consequences of ICUAW-associated muscle weakness or neuropathy-like symptoms after ICU. In 75% at least 1 persistent or previous symmetrical symptom was reported (myopathy-like muscle weakness: 43%; neuropathy-like symptoms: 13%; both: 44%) and rated as incidence of ICUAW. However, only 18% of participants had received an ICUAW diagnosis by their physicians, although 62% had persistent symptoms up to 10y after ICU (5-10y: 46%). Only 37% of participants reported a complete recovery of symptoms, significantly associated with an initially low number of symptoms after ICU ( p &lt; 0.0001), myopathy-like symptoms ( p = 0.024), and younger age at the time of ICU admission (55.7 ± 13.1 vs. 62.6 ± 10.6y, p &lt; 0.001). ICUAW still impaired the QoL at the time of the interview in 74% of affected survivors, with 30% reporting severe impairment. </jats:p></jats:sec><jats:sec><jats:title>Conclusion:</jats:title><jats:p> ICUAW symptoms were disturbingly common in the majority of long-term survivors, indicating that symptoms persist up to 10y and frequently impair QoL. However, only a small number of patients had been diagnosed with ICUAW. Trial registry: Deutsches Register Klinischer Studien (DRKS), https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&amp;TRIAL_ID=DRKS00011593 , registration number: DRKS00011593. </jats:p></jats:sec>